Leuthold Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Leuthold Group’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,138	Closed	-$353K	–	207
2021 Q2	$353K	Sell	2,138 -57	-3%	-$9.52K	0.04%	151
2021 Q1	$337K	Sell	2,195 -55	-2%	-$7.47K	0.04%	153
2020 Q4	$282K	Sell	2,250 -91	-4%	-$10.2K	0.04%	157
2020 Q3	$237K	Sell	2,341 -65	-3%	-$6.63K	0.03%	159
2020 Q2	$234K	Sell	2,406 -34	-1%	-$3.16K	0.03%	142
2020 Q1	$203K	Buy	+2,440	New	+$238K	0.04%	140

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Leuthold Group's PRAH Position: Q3 2021 in Review

Leuthold Group sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,138 shares — an estimated $353K sold.

Leuthold Group first reported a position in PRAH in Q1 2020 and held it in 6 quarters. The position peaked at $353K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Leuthold Group reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Leuthold Group sold 2,138 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $353K.
Leuthold Group first reported a position in PRA Health Sciences, Inc. in Q1 2020 and held it in 6 quarters.
Leuthold Group's PRA Health Sciences, Inc. position peaked at $353K in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Leuthold Group's 13F filing for Q3 2021, filed 15 Nov 2021.